Last update 15 May 2025

Loperamide Hydrochloride/Dimethicone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
LOPERAMIDE HYDROCHLORIDE/SIMETHICONE, Imodium Multi-symptom Relief
Target
Opioid receptors
Action
agonists
Mechanism
Opioid receptors agonists(Opioid receptors agonists)
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication
Acute diarrheaAbdomen distendedDiarrhea+ [1]
Inactive Indication
Muscle Cramp
Originator Organization
Johnson & Johnson Holdco (NA), Inc.Johnson & Johnson Holdco (NA), Inc.
Active Organization
Johnson & Johnson de Colombia SABiotech Pharmaceuticals Pty Ltd
Inactive Organization
Johnson & Johnson Holdco (NA), Inc.Johnson & Johnson Holdco (NA), Inc.
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (26 Jun 1997),
DiarrheaGastrointestinal spasmMuscle Cramp
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC29H34Cl2N2O2
InChIKeyPGYPOBZJRVSMDS-UHFFFAOYSA-N
CAS Registry34552-83-5

Related

4
Clinical Trials associated with Loperamide Hydrochloride/Dimethicone
NCT04186936
/ CompletedPhase 1
An Open-label, Randomized, Fasting, Two-period, Single-dose, Crossover Study to Assess Bioequivalence Between a Combination Caplet With Loperamide Hydrochloride and Simethicone (Janssen-Cilag, France), and Imodium® Express Tablets-lyophilizate (Janssen-Cilag, France) Coadministered With Espumisan® Capsule (Berlin-Chemie AG, Germany), in Healthy Volunteers
NCT00807326
/ CompletedPhase 4
A Randomized, Parallel Group Comparison of Loperamide/Simeticone Caplet, Loperamide/Simeticone Chewable Tablet (IMODIUM® PLUS) and a Probiotic (Saccharomyces Boulardii) in the Treatment of Acute Diarrhea in Adults
NCT00685607
/ CompletedPhase 4
A Placebo-Controlled, Double-Blind, Randomized Pilot Study to Evaluate the Appropriateness of Multiple Endpoints in Measuring the Onset of Clinical Efficacy of Loperamide-Simethicone Caplets in the Treatment of Acute Non-specific Diarrhea
100 Clinical Results associated with Loperamide Hydrochloride/Dimethicone
Login to view more data
100 Translational Medicine associated with Loperamide Hydrochloride/Dimethicone
Login to view more data
100 Patents (Medical) associated with Loperamide Hydrochloride/Dimethicone
Login to view more data
100 Deals associated with Loperamide Hydrochloride/Dimethicone
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Acute diarrhea
Australia
Biotech Pharmaceuticals Pty Ltd
08 Aug 2012
Abdomen distended
United States
Johnson & Johnson de Colombia SA
30 Nov 2000
Diarrhea
United States
Johnson & Johnson Holdco (NA), Inc.Johnson & Johnson Holdco (NA), Inc.
26 Jun 1997
Gastrointestinal spasm
United States
Johnson & Johnson Holdco (NA), Inc.Johnson & Johnson Holdco (NA), Inc.
26 Jun 1997
Muscle Cramp
United States
Johnson & Johnson Holdco (NA), Inc.Johnson & Johnson Holdco (NA), Inc.
26 Jun 1997
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free